Abstract:Background: Reduced endometrium thickness and receptivity are two important reasons for recurrent implantation failure (RIF). In order to elucidate differences between these two types of endometrial defects in terms of molecular signatures, cellular interactions, and structural changes, we systematically investigated the single-cell transcriptomic atlas across three distinct groups: RIF patients with thin endometrium (≤ 6 mm, TE-RIF), RIF patients with normal endometrium thickness (≥ 8 mm, NE-RIF), and fertile individuals (Control). Methods: The late proliferative and mid-secretory phases of the endometrium were collected from three individuals in the TE-RIF group, two in the NE-RIF group, and three in the control group. The study employed a combination of advanced techniques. Single-cell RNA sequencing (scRNA-seq) was utilized to capture comprehensive transcriptomic profiles at the single-cell level, providing insights into gene expression patterns within specific cell types. Scanning and transmission electron microscopy were employed to visualize ultrastructural details of the endometrial tissue, while hematoxylin and eosin staining facilitated the examination of tissue morphology and cellular composition. Immunohistochemistry techniques were also applied to detect and localize specific protein markers relevant to endometrial receptivity and function. Results: Through comparative analysis of differentially expressed genes among these groups and KEGG pathway analysis, the TE-RIF group exhibited notable dysregulations in the TNF and MAPK signaling pathways, which are pivotal in stromal cell growth and endometrial receptivity. Conversely, in the NE-RIF group, disturbances in energy metabolism emerged as a primary contributor to reduced endometrial receptivity. Additionally, using CellPhoneDB for intercellular communication analysis revealed aberrant interactions between epithelial and stromal cells, impacting endometrial receptivity specifically in the TE-RIF group. Conclusion: Overall, our findings provide valuable insights into the heterogeneous molecular pathways and cellular interactions associated with RIF in different endometrial conditions. These insights may pave the way for targeted therapeutic interventions aimed at improving endometrial receptivity and enhancing reproductive outcomes in patients undergoing ART. Further research is warranted to validate these findings and translate them into clinical applications for personalized fertility treatments. Trial registration: Not applicable.

Aberrant expression of oxytocin receptor in endometrium and decidua in women who have experienced recurrent implantation failure

Construction of Implantation Failure Related Lncrna-Mrna Network and Identification of Lncrna Biomarkers for Predicting Endometrial Receptivity

Single-cell transcriptome profiling of the human endometrium of patients with recurrent implantation failure

The Clinical Characteristics of Women with Recurrent Implantation Failure

Integrated Transcriptomic Analysis Reveals Dysregulated Immune Infiltration and Pro-Inflammatory Cytokines in the Secretory Endometrium of Recurrent Implantation Failure Patients

Diverse Endometrial Mrna Signatures During the Window of Implantation in Patients with Repeated Implantation Failure

HOXA-10 and E-cadherin expression in the endometrium of women with recurrent implantation failure and recurrent miscarriage

Altered Expression of C4BPA and CXCL1 Genes in the Endometrium of Patients with Recurrent Implantation Failure after In Vitro Fertilization and Thin Endometrium

Endometrial proteomic profile of patients with repeated implantation failure

Aberrantly Expressed Long Noncoding RNAs in Recurrent Implantation Failure: A Microarray Related Study

Immune profiling and RNA-seq uncover the cause of partial unexplained recurrent implantation failure

Identification of potential biomarkers and immune infiltration characteristics in recurrent implantation failure using bioinformatics analysis

Identification of Differentially Expressed mRNAs and lncRNAs Contributes to Elucidation of Underlying Pathogenesis and Therapeutic Strategy of Recurrent Implantation Failure

Recurrent Implantation Failure: Bioinformatic Discovery of Biomarkers and Identification of Metabolic Subtypes.

Association of angiotensin II and receptors in peri-implantation endometrium with microvessel density and pregnancy outcomes of women with recurrent implantation failure after embryo transfer

Endometrial transcriptome profiling of patients with recurrent implantation failure during hormone replacement therapy cycles

Autophagy markers are dysregulated in the endometrial tissues of patients with unexplained repeated implantation failure

Altered microRNA Profiles of Extracellular Vesicles Secreted by Endometrial Cells from Women with Recurrent Implantation Failure

Identification of key genes, regulatory factors, and drug target genes of recurrent implantation failure (RIF)

Varied cellular abnormalities in thin vs. normal endometrium in recurrent implantation failure by single-cell transcriptomics

Innate and Adaptive Immune Dysregulation in Women with Recurrent Implantation Failure